Donation

Donate
Myeloma Minute
Series
Dr. Sandy Wong ASH abstract on Alnuctumab

Alnuctamab, a BCMA x CD3 T-Cell Engager, in Patients with Relapsed/Refractory Multiple Myeloma

February 2, 2023
ASH
Dr. Joseph Mikhael on the key abstracts presented at ASH 2022

Key Multiple Myeloma Abstracts Presented at ASH 2022

February 1, 2023
ASH
Dr Joseph Mikhael top ASH abstracts on health disparities

Multiple Myeloma Abstracts Dealing with Health Disparities Presented at ASH 2022

February 1, 2023
ASH
Dr Saemundur Rognvaldsson ASH abstract on MGUS

Monoclonal Gammopathy of Undetermined Significance (MGUS) with Multiple Paraproteins: Results from iStopMM

February 1, 2023
ASH
Dr Jesus Berdeja ASH abstract on BMS-986393

Clinical Activity of BMS-986393, a CAR T cell therapy directed at GPRC5D, in Pts with RRMM

February 1, 2023
ASH
Dr. Nizar Bahlis ASH abstract on MagnetisMM-3

Efficacy and Safety of Elranatamab in Patients with Relapsed/Refractory Multiple Myeloma: MagnetisMM-3

January 30, 2023
ASH
Dr. Noopur Raje ASH abstract MagnetisMM-1

Elranatamab Induces Durable Responses for Patients with Relapsed or Refractory Multiple Myeloma

January 28, 2023
ASH
Dr. Ashley Rosko on factors that influence transplant and survival

Multiple Myeloma Transplant: Examining the Intersection of Access, Age and Race

January 27, 2023
ASH
Dr Juan Du ASH Abstract on FasTCAR-T cell therapy

Dual-Targeting FasTCAR-T Cells for First-Line Tx of Transplant-Eligible High-Risk MM

January 26, 2023
ASH
Dr. Tondre Buck abstract on race and myeloma risk assessment

Real-World Multiple Myeloma Risk Factors and Outcomes By Race/Ethnicity in the United States

January 16, 2023
ASH
Dr. Ajai Chari abstract on MonumenTAL-1

Talquetamab in Patients with Relapsed/Refractory Multiple Myeloma: Phase 1/2 Results from MonumenTAL-1

January 12, 2023
ASH
Dr. Saad Usmani abstract on KarMMa2

KarMMa2: Efficacy and Safety of Idecabtagene Vicleucel in High Risk Multiple Myeloma Pts with Early Relapse after ASCT

January 12, 2023
ASH

Give Where Most Needed

Learn More